3D Bioprinting Market Size, Share, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global 3D Bioprinting Market


The global 3D Bioprinting market size is projected to reach US$ 4013.01 million by 2026, from US$ 1378.04 million in 2020, at a CAGR of 19.5% during 2021-2026. This growth is attributed to the rising incidence of chronic diseases, such as heart and kidney failures, increasing aging population, and limited number of organ donors. Advancements in technology & IT within the healthcare industry and rising R&D investments are also likely to boost the market growth.

For instance, in January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands collaborated with Aspect Biosystems, a Canadian company, for the advancements in 3D printing and regenerative medicine. As of 2018, numerous universities and research institutes have invested in the development of highly efficient and better quality bio-implants at low costs.

For instance, 3D bioprinting using graphene, which has high strength than plastic and is highly comfortable and durable. In the recent past, the University of Plymouth with support from Agri-tech Cornwall Project developed skin substitute, which is similar to human skin. The 3D bio-printer is using nanotechnology, which is used to print live skin-based organs within hours. Increasing prevalence of cancer is also one of the key factors boosting the market growth.

For instance, 3D bioprinting of the bio-mimetic microstructure is used for the cancer cell migration studies. Increasing geriatric population base, which is highly susceptible to neurological diseases, cancer, cardiac conditions, and spinal injuries is also expected to contribute to the industry expansion further over the forecast period. In addition, innovations, in terms of technologies and products, shaping the future of the global industry will augment the growth in the years to come.

Market Segmentation, Outlook & Viewpoint: Global 3D Bioprinting Market

Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Magnetic Levitation
  
Inkjet-based
  
Syringe-based
  
Laser-based
  
Others

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Medical
  
Tissue and Organ Generation
  
Medical Pills
  
Prosthetic and Implants
  
Dental
  
Biosensors
  
Consumer/Personal Product Testing
  
Bioinks
  
Food and Animal Product

Key Players, Recent Developments & Regional Insights: Global 3D Bioprinting Market

On the basis of application, the market has been segmented into dental, biosensors, bioinks, medical, food and animal product bioprinting, and consumer/personal product testing. The medical segment is further segmented into tissue and organ generation, prosthetic and implants, and medical pills. The segment is anticipated to have a market share of over 38.0% by 2026.The medical pill is the latest development in the market and is anticipated to witness high growth over the forecast period.

Increasing need for the medicines and advantage of fast and cost-efficient production of bio-drugs using this technology are driving the segment further. The pharmaceutical industry is expected to grow multi-fold, thereby increasing the demand for medical pills. For instance, in March 2016, Aprecia Pharmaceuticals, a U.S.-based pharma company, received the first-ever USFDA approval for the 3D printing for the drug Spritam. The drug has therapeutic action in the treatment of epileptic patients.

Regional Insights

North America is projected to be the dominant regional market over the forecast period. Increasing target population base is expected to be the key factor augmenting the regions growth. The presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region are also expected people the market growth. Furthermore, extensive research activities conducted within the region are said to contribute to the market expansion.

In October 2018, the U.S. FDA awarded a grant of USD 2.5 million to top five research institutions for R&D in bio-manufacturing, including 3D bioprinting. It included Harvard University, Carnegie Mellon University, Rutgers University, Georgia Institute of Technology, and Massachusetts Institute of Technology. The Asia Pacific regional market is expected to witness the highest CAGR over the forecast period.

Presence of the target population and quick adoption of innovations in the regional market are expected to be the prime factors responsible for this growth. Moreover, rising awareness about 3D printing technology, increasing foreign investments, and favorable government policies are further expected to impel the growth. For instance, China introduced Made in China 2025 initiative to foster advanced technology in the 3D printing space. Moreover, Chinas Ministry of Industry and Information Technology released dedicated plan for the commercialization of the industry.

3D Bioprinting Market Share Insights

Key players in the global market include Organovo Holding, Inc.; Luxexcel Group B.V.; TeVido BioDevices, LLC; 3Dynamics Systems Ltd.; Cyfuse Biomedical K.K.; Aspect Biosystems Ltd.; Stratasys Ltd.; Voxeljet A.G.; Bio3D Technologies Pte. Ltd.; Materialise N.V.; Envision TEC; and Solidscape, Inc. (acquired by Prodways Group).
Most of these companies have tie-ups with research institutes and universities that work on grafting and organ regeneration technologies. Companies are also scheduling various exhibitions and seminars to raise awareness about the technology globally. Organovo Holding, Inc. announced a partnership with hair and skin care LOreal for the development of skin tissue with its NovoGen Bioprinting Platform.

Key Insights Covered: Global 3D Bioprinting Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of 3D Bioprinting industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of 3D Bioprinting industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of 3D Bioprinting industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of 3D Bioprinting industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of 3D Bioprinting industry.

Research Methodology: Global 3D Bioprinting Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other